Telomere and telomerase evolution in S. cerevisiae
Telomere and telomerase evolution in S. cerevisiae
批准号:
10359979
负责人:
Melissa Anne Mefford
金额:
$42.6万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-01 至 2024-12-31
关键词:
AddressAgeAgingAllelesArchitectureBehaviorBiologicalBiological ClocksCardiovascular DiseasesCell Cycle ArrestCell ProliferationCell divisionCellsChromosome StructuresChromosomesCosts and BenefitsDNADNA SequenceDNA cassetteDisadvantagedDiseaseEnzymesEquilibriumEukaryotaEvolutionExhibitsFoundationsGenesGeneticGenetic EngineeringGenetic RecombinationGoalsHealthHumanInvestigationKnowledgeLengthLightLinkLongevityMalignant NeoplasmsMental DepressionMutationOrganismPositioning AttributeRNAResearchRibonucleoproteinsRoleSaccharomyces cerevisiaeShapesStructureStructure-Activity RelationshipTelomeraseTelomerase RNA ComponentTelomere MaintenanceTelomere ShorteningTelomere-Binding ProteinsTestingWorkYeastsarmdesignenzyme activityenzyme structurefitnessgain of functiongain of function mutationinnovationinsightloss of function mutationmutantnovelpreventpublic health relevancesenescencetelomeretooluncontrolled cell growth
中文摘要
项目摘要
端粒,由线性染色体末端的重复DNA序列组成,
染色体,作为保护帽。然而,端粒不能完全
在没有核糖核蛋白酶端粒酶的情况下复制。
了解端粒长度和端粒酶之间的微妙平衡
活动对两个最大的人类健康问题具有重要影响:
衰老和癌症端粒已被证明随着年龄的增长而缩短,
“生物钟”限制了细胞分裂的次数。规避
超过85%的癌症异常上调端粒酶
表情这项工作的长期目标是了解
端粒和端粒酶,以及这些细胞成分如何有助于
健康和寿命。开始解开这些广泛的基本
问题,两个具体的调查路线将进行利用强大的
酿酒酵母的遗传可操作性。首先,屏幕上的增益-
端粒酶RNA的功能突变将识别新的等位基因,
通过增加酶的活性来调节端粒。这种功能获得性突变体将脱落
关于端粒酶的基本RNA成分如何促进端粒酶活性的新观点,
酶的整体作用。更活跃的端粒酶也将允许探索
是否更长的端粒会改变生物体的整体适应性。二、酵母
将对菌株进行基因工程改造,使其16个线性菌株中的每一个都环化,
染色体,允许新的实验研究的优势,
真核生物中环状染色体的缺点。这些新颖
酵母菌株将为创造一种创新的真核生物奠定基础,
所有线性染色体环化的有机体,打开了探索
端粒和端粒酶进化的大问题。
英文摘要
PROJECT ABSTRACT
Telomeres, composed of repetitive DNA sequences at the termini of linear
chromosomes, serve as protective caps. However, telomeres cannot be fully
copied during replication without the ribonucleoprotein enzyme telomerase.
Understanding the delicate balance between telomere length and telomerase
activity has important implications for two of the biggest human health concerns:
aging and cancer. Telomeres have been shown to shorten with age, acting as a
“biological clock” limiting the rounds of division a cell can undergo. To circumvent
this proliferative limit, over 85% of cancers aberrantly up-regulate telomerase
expression. The long-term goal of this work is to understand the evolution of
telomeres and telomerase, and how these cellular components contribute to the
health and lifespan of an organism. To begin unraveling these broad fundamental
questions, two specific lines of inquiry will be undertaken harnessing the powerful
genetic manipulability of Saccharomyces cerevisiae. First, a screen for gain-of-
function mutations in telomerase RNA will identify novel alleles that lengthen
telomeres by increasing enzyme activity. Such gain-of-function mutants will shed
new light on how the essential RNA component of telomerase contributes to the
overall action of the enzyme. More active telomerase will also permit exploration
of whether longer telomeres alter total fitness of the organism. Second, yeast
strains will be genetically engineered to circularize each of their 16 linear
chromosomes, allowing novel experimental investigation of the advantages and
disadvantages of circular chromosomes in a eukaryotic organism. These novel
yeast strains will build a foundation for creating an innovative eukaryotic
organism with all linear chromosomes circularized, opening the door to explore
big picture questions of telomere and telomerase evolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: